- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02474238
Comparing Nd:YAG Laser and Sequential Double Frequency YAG-Nd:YAG Laser Iridotomy
August 24, 2018 updated by: Weerawat Kiddee, Prince of Songkla University
Randomized Clinical Trial Comparing Neodynium:Ytrium-aluminium-garnet (Nd:YAG) Laser and Sequential Double Frequency YAG-Nd:YAG Laser Iridotomy in Patients With Dark Iris
No single type of laser or set of laser parameters is appropriate for all type of irides.
Pure Nd:YAG laser iridotomy is very effective in the light color irides.
It was considered as the gold standard for iridotomy.
It, however, is less effective and causes some complication such as iris hemorrhage especially in patients with dark iris.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
By using the double frequency YAG to make the initial bore and the Nd:YAG laser to complete the perforation, the technique should be able to effectively combine most of the advantages of both lasers whilst avoiding their disadvantages.
It is possibly the ideal iridotomy technique to use in the Asian irides.
The investigators aim to study the energy use for laser iridotomy comparing between the two techniques as well as objectively measure the variables associated with complications.
Study Type
Interventional
Enrollment (Actual)
82
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Songkhla
-
Hat Yai, Songkhla, Thailand, 90110
- Weerawat Kiddee
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
Patient in need to have a laser iridotomy
- primary angle closure glaucoma or
- primary angle closure or
- primary angle closure suspect (needed repeated pupil dilation) or
- fellow eyes of acute angle closure crisis, and
- Age of at least 18 years, and
- Dark iris patients (only black and dark brown color)
Exclusion Criteria:
- Eye with acute angle closure crisis
- Active conjunctiva or corneal infection or inflammation
- Active anterior uveitis
- History of any prior laser treatment
- History intraocular surgery
- Eye with corneal scar
- Corneal haziness obscure iridotomy site
- Endothelial cell count less than 1000 cells/mm2 (pre-laser)
- Iris color other than black or dark brown
- Inability to sit at the slit lamp to have laser done
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: The sequential technique
By using the double frequency YAG laser to make the initial bore and the Nd:YAG laser to complete the perforation on iris.
|
By using 'the double frequency YAG laser' to make the initial bore and 'the Nd:YAG laser' to complete the perforation on iris.
|
|
Active Comparator: The pure Nd:YAG laser technique
By using the pure Nd:YAG to make a complete perforation on iris.
|
By using 'the pure Nd:YAG laser' to make a complete perforation on iris.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Laser energy
Time Frame: 1-hour
|
Total energy used to create patency on the iris
|
1-hour
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Bleeding
Time Frame: 1-hour
|
iris bleeding immediate after laser reported as Yes or No
|
1-hour
|
|
Corneal endothelial cell count
Time Frame: 12-month
|
Corneal endothelial cell count directly over the area of laser
|
12-month
|
|
Central corneal thickness
Time Frame: 12-month
|
Central corneal thickness
|
12-month
|
|
Patency of iridotomy
Time Frame: 12-month
|
Iridotomy patency is confirmed objectively reported as yes or no
|
12-month
|
|
Intraocular pressure spike
Time Frame: 1-hour
|
Intraocular pressure spike if present mean that IOP evelation of at least 8mmHg from baseline intraocular pressure
|
1-hour
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Asst.Prof.Weerawat Kiddee, MD, Prince of Songkla University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2015
Primary Completion (Actual)
August 1, 2018
Study Completion (Actual)
August 1, 2018
Study Registration Dates
First Submitted
June 11, 2015
First Submitted That Met QC Criteria
June 12, 2015
First Posted (Estimate)
June 17, 2015
Study Record Updates
Last Update Posted (Actual)
August 27, 2018
Last Update Submitted That Met QC Criteria
August 24, 2018
Last Verified
August 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- EC-58-093-02-1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Angle Closure Glaucoma
-
National University Hospital, SingaporeCompletedChronic Angle Closure Glaucoma | Primary Angle Closure | Primary Angle Closure Suspect | Fellow Eyes of Acute Angle Closure GlaucomaSingapore
-
Chunyan Qiao_2021RecruitingAngle-Closure GlaucomaChina
-
Khoo Teck Puat HospitalCompletedPrimary Angle-Closure Glaucoma | Primary Angle Closure Without Glaucoma DamageSingapore
-
Peking University People's HospitalRecruiting
-
Peking University People's HospitalRecruitingPrimary Angle-closure GlaucomaChina
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityNot yet recruitingPrimary Angle-Closure Glaucoma
-
Alcon ResearchCompletedAngle-closure GlaucomaUnited States
-
Omar SaidCompletedGlaucoma,Primary Open-Angle ,Primary Angle ClosureEgypt
-
New York Glaucoma Research InstituteUnknownChronic Angle-closure GlaucomaUnited States
-
Assaf-Harofeh Medical CenterUnknown
Clinical Trials on The sequential technique
-
Universidad de AntioquiaNot yet recruitingIntubation; Difficult or Failed | Airway Disease | Ultrasound TherapyColombia
-
University of IndianapolisUnknownSpinal Nerve Root Disorder NosUnited States
-
University of ValenciaCompleted
-
Washington University School of MedicineCompletedCommunication | Behavior and Behavior MechanismsUnited States
-
University Hospital, GrenobleLaboratoire de Psychologie et NeuroCognition; Laboratoire interuniversitaire...Not yet recruitingMultiple Sclerosis | Quality of Life (QOL)France
-
University Hospital OstravaCompleted
-
Aswan UniversityCompletedMask Ventilation | Obesity & Overweight | Obese Patients (BMI ≥ 30 kg/m²) | Bag-mask VentilationEgypt
-
Shahid Beheshti University of Medical SciencesUnknownHorizontal Strabismus With High AC/A RatioIran, Islamic Republic of
-
St. Justine's HospitalRecruiting
-
Seoul National University HospitalCompleted